BioPharma Credit PLC (BPCR.L)
USD 0.89
(0.91%)
USD 0.89
(0.91%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 108.45 Million USD | -40.51% |
| 2022 | 182.31 Million USD | 114.59% |
| 2021 | 84.95 Million USD | -4.69% |
| 2020 | 89.13 Million USD | -27.13% |
| 2019 | 122.32 Million USD | 74.38% |
| 2018 | 70.14 Million USD | 158.63% |
| 2017 | 27.12 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 35.96 Million USD | 91.66% |
| 2024 Q2 | 35.96 Million USD | 0.0% |
| 2023 Q4 | 18.76 Million USD | -0.01% |
| 2023 Q1 | 35.46 Million USD | -68.93% |
| 2023 FY | 108.45 Million USD | -40.51% |
| 2023 Q2 | 35.46 Million USD | 0.0% |
| 2023 Q3 | 18.76 Million USD | -47.09% |
| 2022 Q3 | 57.07 Million USD | -16.27% |
| 2022 Q1 | 34.09 Million USD | -16.25% |
| 2022 FY | 182.31 Million USD | 114.59% |
| 2022 Q4 | 114.14 Million USD | 100.0% |
| 2022 Q2 | 68.16 Million USD | 99.91% |
| 2021 Q1 | 22.12 Million USD | -54.64% |
| 2021 Q4 | 40.71 Million USD | 99.91% |
| 2021 Q2 | 44.24 Million USD | 100.0% |
| 2021 Q3 | 20.36 Million USD | -53.97% |
| 2021 FY | 84.95 Million USD | -4.69% |
| 2020 FY | 89.13 Million USD | -27.13% |
| 2020 Q4 | 48.77 Million USD | 100.1% |
| 2020 Q1 | 20.2 Million USD | -4.71% |
| 2020 Q2 | 40.36 Million USD | 99.82% |
| 2020 Q3 | 24.37 Million USD | -39.62% |
| 2019 Q2 | 39.97 Million USD | 0.0% |
| 2019 FY | 122.32 Million USD | 74.38% |
| 2019 Q4 | 21.2 Million USD | 0.0% |
| 2019 Q3 | 21.2 Million USD | -46.96% |
| 2019 Q1 | 39.97 Million USD | 108.06% |
| 2018 FY | 70.14 Million USD | 158.63% |
| 2018 Q3 | 19.21 Million USD | 7.74% |
| 2018 Q2 | 17.83 Million USD | 0.0% |
| 2018 Q1 | 17.83 Million USD | 1.67% |
| 2018 Q4 | 19.21 Million USD | 0.0% |
| 2017 FY | 27.12 Million USD | 0.0% |
| 2017 Q4 | 17.53 Million USD | 0.0% |
| 2017 Q2 | 7.11 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ameriprise Financial, Inc. | - USD | -Infinity% |
| Gladstone Investment Corporation | 48.2 Million USD | -124.986% |
| Principal Financial Group, Inc. | 8.59 Billion USD | 98.738% |
| Africa Opportunity Fund Limited | -396.15 Thousand USD | 27475.579% |
| BH Macro Limited | -42.01 Million USD | 358.128% |
| CATCo Reinsurance Opportunities Fund Ltd. | 5.44 Million USD | -1893.249% |
| Craven House Capital Plc | -5.45 Million USD | 2089.908% |
| JPEL Private Equity Limited | -4.52 Million USD | 2497.745% |
| Pershing Square Holdings, Ltd. | 2.65 Billion USD | 95.92% |
| Ecofin U.S. Renewables Infrastructure Trust PLC | -6.72 Million USD | 1713.119% |
| RTW Venture Fund Limited | -2.51 Million USD | 4412.17% |
| Tufton Oceanic Assets Limited | 76.06 Million USD | -42.583% |
| Symphony International Holdings Limited | -111.89 Million USD | 196.918% |
| Tetragon Financial Group Limited | 164.8 Million USD | 34.193% |
| Taylor Maritime Investments Limited | -51.92 Million USD | 308.854% |
| TMT Investments PLC | 6.08 Million USD | -1681.353% |
| Third Point Investors Limited | 28.19 Million USD | -284.614% |